Propylthiouracil, usually called PTU, is an antithyroid medication used to treat hyperthyroidism, the condition in which the thyroid gland produces too much hormone. It works by interfering with the production of thyroid hormones inside the gland and, unlike its more commonly prescribed cousin methimazole, also blocks the conversion of one thyroid hormone into another in the rest of the body. That dual action makes PTU uniquely valuable in certain situations, particularly thyroid emergencies and early pregnancy, even though methimazole has largely replaced it as the everyday first-line drug for Graves’ disease and other forms of overactive thyroid.
How PTU Slows Down an Overactive Thyroid
PTU acts primarily inside the thyroid gland by competing with a protein called thyroglobulin for a key chemical step. Normally, an enzyme in the gland oxidizes iodine so it can attach to thyroglobulin and eventually form thyroid hormones. PTU gets in the way of that attachment. Research in rat thyroid tissue found that residual PTU concentrations were high enough to explain the observed inhibition through this competitive, reversible mechanism, meaning PTU keeps stealing the oxidized iodine away from the protein that needs it.
PTU has a second trick that methimazole does not share. Outside the thyroid, the body converts the storage hormone T4 into the more active hormone T3 using an enzyme called 5′-deiodinase. PTU inhibits that enzyme in most peripheral organs.1Endocrinology. A New Class of Propylthiouracil Analogs: Comparison of 5′-Deiodinase Inhibition and Antithyroid Activity In studies of people who had no functioning thyroid tissue and were maintained on T4 replacement, adding PTU blocked the conversion of T4 to T3 and caused T3 levels to fall while T4 levels rose.2PubMed Central. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man This peripheral blocking effect is what makes PTU the drug of choice when you need to lower active thyroid hormone levels fast.
When PTU Is Preferred Over Methimazole
For routine treatment of Graves’ disease, methimazole is the standard. Head-to-head comparisons have consistently shown it to be more potent. In one trial of 30 newly diagnosed Graves’ patients, a single daily dose of 15 mg of methimazole brought thyroid hormone levels down significantly more than a single daily dose of 150 mg of PTU over 12 weeks.3PubMed. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves’ hyperthyroidism Another study found that roughly 29% of patients on PTU given twice daily failed to reach normal thyroid levels within three months, compared with about 14% on a comparable methimazole schedule.4PubMed. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves’ disease Methimazole also has the practical advantage of once-daily dosing, since PTU’s short half-life of roughly one to two hours usually requires taking it two or three times a day.5PubMed. Clinical pharmacokinetics of antithyroid drugs
So why does PTU still exist? Two scenarios keep it relevant. The first is thyroid storm, a rare, life-threatening surge of thyroid hormones that can happen during surgery, infection, or uncontrolled hyperthyroidism. PTU is preferred in this crisis because blocking peripheral T4-to-T3 conversion can drop T3 levels by about 45% within the first 24 hours of treatment.6IntechOpen. Perioperative Thyroid Storm: A Medical and Surgical Emergency Methimazole cannot match that speed because it works only inside the gland. The second scenario is early pregnancy, discussed below. A third, more niche use is in patients who have experienced a serious allergic reaction to methimazole and have no other options before definitive treatment like radioactive iodine or surgery.
PTU in Pregnancy
Hyperthyroidism during pregnancy needs treatment because uncontrolled disease raises the risk of complications for both mother and baby. Both PTU and methimazole cross the placenta, but methimazole has been linked to specific birth defects including choanal atresia (a blockage of the nasal passages) and esophageal atresia (a gap in the esophagus). These defects are most associated with first-trimester exposure.7PubMed. Management of hyperthyroidism during pregnancy and lactation
A systematic review and meta-analysis confirmed that PTU is the safer alternative during the first trimester.8PubMed Central. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis Another meta-analysis found that although PTU still carries a slightly elevated risk of birth defects compared with no drug exposure, the risk is the smallest among the antithyroid options and may be similar to the risk seen in women with untreated hyperthyroidism.9PubMed Central. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations Current guidelines recommend PTU during the first trimester, then switching to methimazole for the second and third trimesters to reduce the risk of PTU-related liver damage in the mother.10PubMed. Management of hyperthyroidism during pregnancy and lactation
Safety During Breastfeeding
PTU is about 80% bound to proteins in the blood, which limits how much of it passes into breast milk.11PubMed. Clinical pharmacokinetics of antithyroid drugs In practice, the amount reaching a nursing infant is tiny. One study tested thyroid function in infants whose mothers took doses as high as 750 mg of PTU daily and found no adverse effects on the babies’ thyroid status.12PubMed. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil A review of the available evidence concluded that women on either PTU or methimazole should not be discouraged from breastfeeding, as the benefits outweigh the minimal theoretical risks.13PubMed Central. Pharmacologic treatment of hyperthyroidism during lactation This is reassuring for new mothers who need ongoing antithyroid therapy, since telling them to choose between their medication and breastfeeding was once a common but unnecessary practice.
Serious Side Effects
PTU’s most feared side effect is liver damage. This risk is rare in adults but significant enough that the U.S. Food and Drug Administration issued a black-box warning about PTU-related hepatotoxicity.14PubMed Central. 63 years and 715 days to the “boxed warning”: unmasking of the propylthiouracil problem The liver damage can range from mild enzyme elevations to fulminant liver failure requiring transplantation. It is unpredictable and is not dose-dependent in the way that many drug side effects are, which means routine blood tests may catch it early but cannot reliably prevent it. This hepatotoxicity risk is the main reason methimazole replaced PTU as the default antithyroid drug for most patients.
The concern is even sharper in children. A review of pediatric cases found enough evidence of serious liver injury that experts recommended PTU should not be used as first-line therapy in children at all, and that children already on the drug should be switched to an alternative.15PubMed Central. Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use
Another serious but uncommon risk shared by both PTU and methimazole is agranulocytosis, a dramatic drop in a type of white blood cell called neutrophils. The reported incidence is roughly 0.1% to 1% of patients on antithyroid drugs.16PubMed Central. Asymptomatic Propylthiouracil Induced Agranulocytosis in a Patient with Toxic Nodular Goiter: A Rare Case Report In PTU-related cases, the mechanism appears to be immune-mediated: the drug triggers the formation of antibodies that attack neutrophils as they mature.17PubMed Central. Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management Without enough neutrophils, the body cannot fight off infections, so a sore throat or unexplained fever in someone taking PTU is treated as a medical emergency until blood counts are checked. Baseline white blood cell counts before starting therapy, along with patient education about warning signs, are standard practice.
Vasculitis and Autoantibodies
A less well-known side effect, particularly with longer use, is the development of ANCA-associated vasculitis. PTU can trigger the body to produce antineutrophil cytoplasmic antibodies (ANCAs), which attack the walls of small blood vessels.18PubMed Central. Propylthiouracil-Induced Skin Vasculitis This can show up as skin lesions, kidney inflammation, joint pain, or more widespread organ damage. In one reported case, a 41-year-old woman with Graves’ disease developed severely itchy purplish skin lesions on her legs nearly two years after starting PTU. Biopsy showed thrombotic vasculitis, and the diagnosis was attributed to the drug.19PubMed Central. Propylthiouracil-induced vasculitis
The clinical takeaway is that patients on long-term PTU who develop unexplained skin rashes, joint symptoms, or blood in the urine should have ANCA levels checked. The vasculitis usually improves after stopping the drug, though some patients need additional immunosuppressive treatment. This is another reason clinicians tend to reserve PTU for situations where methimazole is not an option, or for limited-duration use in early pregnancy and thyroid storm.
How PTU Moves Through the Body
PTU is absorbed quickly from the gut, and its plasma half-life is short, with a median of about 1.3 hours in healthy volunteers who received the drug intravenously.20PubMed. Disposition of intravenous propylthiouracil That short half-life is the reason PTU needs to be taken multiple times per day, usually every six to eight hours. Its volume of distribution is around 28 to 30 liters, which is somewhat smaller than methimazole’s roughly 40 liters.21PubMed. Clinical pharmacokinetics of antithyroid drugs The high degree of protein binding, about 80%, has practical consequences: it keeps more of the drug in the bloodstream and out of breast milk and fetal circulation, which is one reason PTU is favored over the less protein-bound methimazole in early pregnancy and breastfeeding.
Less than 10% of PTU is excreted unchanged in the urine. The kidneys actually reabsorb most of the filtered drug, as shown by urinary clearance data far lower than what would be expected based on the free fraction in blood.22PubMed. Disposition of intravenous propylthiouracil The detailed metabolic pathways for PTU remain only partially mapped, which is somewhat surprising for a drug that has been in clinical use since the 1940s.
A History That Started by Accident
The antithyroid drugs, including PTU, owe their existence to serendipity. In the 1940s, several investigators noticed that certain sulfur-containing compounds caused goiters in laboratory animals. Edwin B. Astwood recognized the therapeutic potential and pioneered the use of these compounds to treat hyperthyroidism.23European Journal of Endocrinology. Antithyroid drug therapy: 70 years later The earliest antithyroid drugs were fairly toxic, and PTU along with methimazole were developed specifically as less harmful alternatives.24PubMed. The Origin of Antithyroid Drugs For decades, PTU and methimazole were used more or less interchangeably. It was only as evidence accumulated about liver toxicity that the medical community shifted toward methimazole as the default and confined PTU to specific circumstances.
The Bitter Taste Connection
PTU has a second life entirely outside of medicine. A closely related compound, 6-n-propylthiouracil (often abbreviated PROP, the same molecule), has been used for decades in genetics and taste research because some people find it intensely bitter while others can barely taste it at all. This variation is largely driven by a gene called TAS2R38, which encodes a bitter taste receptor on the tongue.
People with two copies of the tasting version of the gene (PAV/PAV) tend to perceive PROP as strongly bitter, while those with two copies of the non-tasting version (AVI/AVI) often cannot detect it at concentrations below about 0.15 millimolar.25Chemical Senses. Supertasting and PROP Bitterness Depends on More Than the TAS2R38 Gene People who are heterozygous, carrying one of each, fall somewhere in between, though they tend to taste more bitterness than the AVI/AVI group.26PubMed Central. Bitter receptor gene (TAS2R38), 6-n-propylthiouracil (PROP) bitterness and alcohol intake A large study of children from the Avon Longitudinal Study confirmed the association and also found evidence of a genetic basis for intermediate tasting ability.27PubMed Central. Refining associations between TAS2R38 diplotypes and the 6-n-propylthiouracil (PROP) taste test: findings from the Avon Longitudinal Study of Parents and Children
The genetics are not quite as clean as a simple dominant-recessive story, though. Research has shown that TAS2R38 genotype does not fully predict taste response. The number of fungiform papillae on a person’s tongue and other still-unidentified factors also play a role, which is why some people with the “taster” genotype report only moderate bitterness while some with the “non-taster” genotype can still detect the compound at higher concentrations.28Chemical Senses. Supertasting and PROP Bitterness Depends on More Than the TAS2R38 Gene PROP tasting status has been linked to food preferences, vegetable avoidance, and even alcohol intake, making it one of the most studied single-gene taste traits in humans.
PTU as a Research Tool
Beyond the clinic and the taste lab, PTU is widely used in animal research as a reliable way to create hypothyroidism in laboratory animals. By adding it to drinking water at known concentrations, researchers can dial thyroid hormone levels down in a controlled fashion to study how thyroid deficiency affects development, the brain, and other organs.
In developmental neuroscience, administering PTU to pregnant rats through their drinking water produces hypothyroid offspring whose brains can then be studied. One study exposed developing rats to 15 parts per million of PTU from late pregnancy through weaning and found that the animals had dramatically reduced thyroid hormones at weaning and lasting deficits in body weight. When brain function was tested months later, the rats showed impaired electrical signaling in the hippocampus, a region critical for learning and memory.29PubMed. Propylthiouracil (PTU)-induced hypothyroidism in the developing rat impairs synaptic transmission and plasticity in the dentate gyrus of the adult hippocampus Other researchers have used even lower doses, from 1 to 3 parts per million, to model milder, more environmentally relevant levels of thyroid disruption and assess how subtle hormone changes during development affect the brain.30Toxicological Sciences. Impact of Low-Level Thyroid Hormone Disruption Induced by Propylthiouracil on Brain Development and Function
PTU also plays a role in environmental toxicology. Because thyroid hormones drive metamorphosis in amphibians, PTU is used as a positive control in assays designed to screen chemicals for thyroid-disrupting activity. Exposing tadpoles of the African clawed frog to PTU delays or completely blocks metamorphosis in a dose-dependent way, and the effect is visible both in outward development (limb growth, tail resorption) and in microscopic changes to the thyroid gland itself, including gland swelling and altered cell structure.31Toxicological Sciences. Progress towards Development of an Amphibian-Based Thyroid Screening Assay Using Xenopus laevis A related species showed even greater sensitivity on histological endpoints: changes in thyroid tissue were detectable at PTU concentrations as low as 2 mg per liter, well before any visible developmental delay appeared.32PubMed. The impact of the goitrogen 6-propylthiouracil (PTU) on West-African clawed frog (Xenopus tropicalis) exposed during metamorphosis These amphibian assays are now part of international screening programs for endocrine-disrupting chemicals, and PTU is the benchmark compound that validates whether the test system is working correctly.33Environmental Toxicology and Chemistry. Description and initial evaluation of a Xenopus metamorphosis assay for detection of thyroid system‐disrupting activities of environmental compounds
In rodent models, PTU-induced hypothyroidism has also been used to study downstream organ damage. One experiment in juvenile rats used 0.05% PTU in drinking water for six weeks and found measurable liver and kidney toxicity from the resulting hypothyroid state, providing a platform for testing whether protective compounds like thymoquinone could offset the damage.34PubMed Central. Thymoquinone Ameliorate Hepatorenal Toxicity Associated With Propylthiouracil-Induced Hypothyroidism in Juvenile Rats The versatility of PTU as a research chemical, from clinical pharmacology to ecology to developmental biology, reflects the central importance of thyroid hormone in nearly every branch of vertebrate physiology.